[HTML][HTML] Analysis of attitudes and practices influencing adherence to seasonal malaria chemoprevention in children under 5 years of age in the Dosso Region of Niger

DC Koko, A Maazou, H Jackou, C Eddis - Malaria Journal, 2022 - Springer
Seasonal malaria chemoprevention (SMC) consists of the intermittent administration of a 3
day course of anti-malarial medications during the months of highest malaria risk in the …

Contextual Factors to Improve Implementation of Malaria Chemoprevention in Children: A Systematic Review.

P Gatiba, J Laury, L Steinhardt, J Hwang… - The American Journal …, 2023 - europepmc.org
Malaria remains a leading cause of childhood morbidity and mortality in sub-Saharan Africa,
particularly among children under 5 years of age. To help address this challenge, the WHO …

[HTML][HTML] Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial

E Bottieau, M Mbow, I Brosius, C Roucher, CT Gueye… - Nature Medicine, 2024 - nature.com
Schistosomiasis treatment entirely relies on a single drug, praziquantel, prompting research
into alternative therapeutics. Here we evaluated the efficacy and safety of the antimalarial …

[HTML][HTML] The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria …

M Cairns, A Barry, I Zongo, I Sagara, SR Yerbanga… - BMC medicine, 2022 - Springer
Background A recent trial of 5920 children in Burkina Faso and Mali showed that the
combination of seasonal vaccination with the RTS, S/AS01E malaria vaccine (primary series …

[HTML][HTML] A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

A Nuwa, K Baker, C Bonnington, M Odongo… - Malaria Journal, 2023 - Springer
Background Until recently, due to widespread prevalence of molecular markers associated
with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern …

[HTML][HTML] Household-level effects of seasonal malaria chemoprevention in the gambia

S Soremekun, B Conteh, A Nyassi… - Communications …, 2024 - nature.com
Background In 2022 the WHO recommended the discretionary expansion of the eligible age
range for seasonal malaria chemoprevention (SMC) to children older than 4 years. Older …

[HTML][HTML] The Prevalence of Human Plasmodium Species during Peak Transmission Seasons from 2016 to 2021 in the Rural Commune of Ntjiba, Mali

F Dao, L Dembele, B Diarra, F Sogore… - Tropical Medicine and …, 2023 - mdpi.com
Up-to-date knowledge of key epidemiological aspects of each Plasmodium species is
necessary for making informed decisions on targeted interventions and control strategies to …

Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina Faso: a case-control study

ME Roh, I Zongo, A Haro, L Huang… - The Journal of …, 2023 - academic.oup.com
Background Despite scale-up of seasonal malaria chemoprevention (SMC) with sulfadoxine-
pyrimethamine and amodiaquine (SP-AQ) in children 3–59 months of age in Burkina Faso …

[HTML][HTML] Modelling the relative cost-effectiveness of the RTS, S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis

HM Topazian, N Schmit, I Gerard-Ursin, GD Charles… - Vaccine, 2023 - Elsevier
Abstract Background The World Health Organization has recommended a 4-dose schedule
of the RTS, S/AS01 (RTS, S) vaccine for children in regions of moderate to high P …

[HTML][HTML] Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review

M Xu, YX Hu, SN Lu, MA Idris, SD Zhou, J Yang… - Infectious Diseases of …, 2023 - Springer
Background Children under five are the vulnerable population most at risk of being infected
with Plasmodium parasites, especially in the Sahel region. Seasonal malaria …